Cargando…
HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of Curcuma aeruginosa Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening
Human immunodeficiency virus type-1 (HIV-1) infection causes acquired immunodeficiency syndrome (AIDS). Currently, several anti-retroviral drugs are available, but adverse effects of these drugs have been reported. Herein, we focused on the anti-HIV-1 activity of Curcuma aeruginosa Roxb. (CA) extrac...
Autores principales: | Sillapachaiyaporn, Chanin, Rangsinth, Panthakarn, Nilkhet, Sunita, Moungkote, Nuntanat, Chuchawankul, Siriporn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621417/ https://www.ncbi.nlm.nih.gov/pubmed/34832897 http://dx.doi.org/10.3390/ph14111115 |
Ejemplares similares
-
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach
por: Rangsinth, Panthakarn, et al.
Publicado: (2021) -
Neuroprotective Effects against Glutamate-Induced HT-22 Hippocampal Cell Damage and Caenorhabditis elegans Lifespan/Healthspan Enhancing Activity of Auricularia polytricha Mushroom Extracts
por: Sillapachaiyaporn, Chanin, et al.
Publicado: (2021) -
Anti-HIV-1 protease activity of the crude extracts and isolated compounds from Auricularia polytricha
por: Sillapachaiyaporn, Chanin, et al.
Publicado: (2019) -
HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies
por: Sillapachaiyaporn, Chanin, et al.
Publicado: (2019) -
Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection
por: Prasansuklab, Anchalee, et al.
Publicado: (2020)